Please try another search
Symbol | Exchange | Currency | ||
---|---|---|---|---|
SHWGY | OTC Markets | USD | Delayed | |
8199 | Frankfurt | EUR | Delayed | |
1066 | Hong Kong | HKD | Delayed |
Shandong Weigao Group Medical Polymer Company Limited engages in the research and development, production, wholesale, and sale of medical devices in the People’s Republic of China. It operates through Medical Device Products, Orthopaedic Products, Interventional Products, Pharma Packaging Products, Blood Management Products, and Others segments. The company offers single use medical consumables and materials, including infusion sets, syringes, blood bags and blood component segregators consumable, blood sampling products, prefilled syringes for pre-pack medication and medical needles which mainly include intravenous needles, syringe needles, intravenous catheter needles, blood sampling needles and irregular needles; orthopedic materials and instruments, including trauma products of steel plates and screws, spinal implants, and artificial joints; and blood purification consumables and equipment, including puncture needles, extracorporeal blood circuit for blood purification sets, dialyzers and related consumables. It also provides tumour and blood vessel interventional instruments; flushing syringes; blood collection, irradiation, storage, separation and sterilization products; implantation materials and artificial organs; medical PVC granules, plastic packing bags, and carton boxes; medical polymer materials and products; injection puncture Instruments; medicines; and X-ray based irradiation machines. In addition, it is involved in the finance leasing and factoring business; provision of enterprise management advisory services, logistics and storage, and computer technical services; and sale of electronic products. The company was incorporated in 2000 and is based in Weihai, the People’s Republic of China.
Name | Age | Since | Title |
---|---|---|---|
Meijun Gu | 46 | 2020 | Chairman of the Supervisors |
Zhuangqiu Zhang | 48 | 2022 | Employee Representative Supervisor |
Rinan Cong | 43 | 2021 | CEO & Executive Director |
Jing Long | 49 | 2013 | Executive Chairman of the Board & Compliance Officer |
Qiang Li | 48 | 2022 | Independent Non-Executive Director |
Guohui Li | 53 | 2022 | Independent Non-Executive Director |
Dapeng Song | 47 | 2022 | Shareholders Representative Supervisor |
Zhengpeng Tang | 53 | 2021 | Vice Chairman |
Lin Chen | 47 | 2021 | Non-Executive Director |
Hong Meng | 58 | 2022 | Independent Non-Executive Director |
Junqiang Lu | 50 | 2022 | Executive Director |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review